Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Pivotal Trial of the Boomerang Catheter for pDVA

NCT: NCT06311773 · ENROLLING_BY_INVITATION

NCT IDNCT06311773
StatusENROLLING_BY_INVITATION
Start Date2024-04-16
Completion2030-03-31
SponsorAveera Medical, Inc. (INDUSTRY)
First posted
Last updated

Brief Summary

The purpose of this study is to establish the safety and effectiveness of the Boomerang Catheter for percutaneous Deep Venous Arterialization (pDVA) to treat no-option Chronic Limb-Threatening Ischemia.

Frequently Asked Questions

What is Pivotal Trial of the Boomerang Catheter for pDVA?

Pivotal Trial of the Boomerang Catheter for pDVA is a clinical trial registered under NCT06311773. Current status: ENROLLING_BY_INVITATION.

What is the status of NCT06311773?

The current status of NCT06311773 (Pivotal Trial of the Boomerang Catheter for pDVA) is: ENROLLING_BY_INVITATION.

When did Pivotal Trial of the Boomerang Catheter for pDVA start?

Pivotal Trial of the Boomerang Catheter for pDVA started on 2024-04-16.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑